Liraglutide is a glucose-like peptide 1 agonist, currently used as an effective weight-loss
treatment. Its mechanism of action has not yet been elucidated. We want to investigate
whether liraglutide affects MMC activity, gastrointestinal hormone release, glucose whole
blood levels, hunger ratings and ad libitum food intake in healthy volunteers.